Exceptional purity for peptide research
We've been sourcing research-grade peptides for several years. Rainbow Peptide's vials consistently pass our HPLC verification — purity exceeds 98% every batch. COA matched our internal testing exactly.
Orforglipron oral non-peptide GLP-1 receptor agonist in capsule format. Small-molecule metabolic signaling research compound with Phase III ATTAIN-DM weight loss data. COA included.
| Format | Capsule |
|---|---|
| Dosage | See COA / 30 capsules |
| Purity | >98% |
In Stock — Overnight and 2–3 day delivery available
Orforglipron (LY3502970) is an orally active, non-peptide small-molecule GLP-1 receptor agonist developed by Eli Lilly. Unlike peptide-based GLP-1 agonists (semaglutide, liraglutide), orforglipron does not require syringe administration and is stable at room temperature. Phase III ATTAIN-DM trial data demonstrated up to 16.2% weight loss at 36 weeks. These capsules enable research into non-peptide GLP-1R activation mechanisms and oral versus injectable pharmacodynamic comparisons.
Orforglipron is studied in obesity, type 2 diabetes, NAFLD, and the comparative pharmacology of peptide vs. non-peptide GLP-1R agonists. Compare with Retatrutide vials (triple agonist) and Tirzepatide capsules (dual agonist) for comprehensive GLP-1R pathway research.
For Research Use Only. Rainbow Peptide supplies this compound exclusively for in vitro and laboratory research purposes. Not for human or veterinary use.
Third-Party Verified
We don't just claim purity — we prove it. Every batch of Orforglipron Capsules is independently tested by an accredited third-party laboratory before it reaches you. Your COA is linked to your specific lot number.
Verified purchases from active research labs and scientists
We've been sourcing research-grade peptides for several years. Rainbow Peptide's vials consistently pass our HPLC verification — purity exceeds 98% every batch. COA matched our internal testing exactly.
Third order now. Consistent batch-to-batch results matter enormously in long-term research. Certificate of Analysis is detailed with mass spec data. Would not switch sources.
Verified against our reference standards. Purity >98.2% by HPLC. Packaging was appropriate for temperature-sensitive peptides. Will re-order.